azasetron has been researched along with Brain Ischemia in 1 studies
azasetron: a selective 5-HT3 receptor antagonist; structure given in first source;
Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kagami, Y | 1 |
| Shigenobu, S | 1 |
| Watanabe, S | 1 |
1 other study available for azasetron and Brain Ischemia
| Article | Year |
|---|---|
Neuroprotective effect of 5-HT3 receptor antagonist on ischemia-induced decrease in CA1 field potential in rat hippocampal slices.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain Ischemia; Bridged Bicyclo Compounds; Bridged Bicyclo Compoun | 1992 |